global

The pharmaceutical and life sciences industry has witnessed significant shifts in market dynamics, scientific advancements, and the impact of the COVID-19 pandemic. Consequently, the discussion around fixed versus variable commercial launch models has become increasingly pertinent. This blog explores the … Read More

The pharmaceutical industry is at a crossroads when it comes to managing drug lifecycles, from launch to maturity. A pivotal decision lies in choosing between building internal expertise and leveraging external partner expertise. This strategic choice significantly impacts an organization’s … Read More

In today’s fast-paced and competitive business world, the shift from product-centric to customer-centric approaches has become a defining factor for an organization’s success. Understanding what customer centricity means and embracing it as a strategic imperative can significantly impact an organization’s … Read More

Background The biotechnology and pharmaceutical industries are facing significant challenges with their existing business models due to expiring drug patents, also known as patent cliff. Patents on drugs are typically for twenty years from the patent approval until expiration, although … Read More

Given the changes in market due to coronavirus pandemic, pharmaceutical companies are advised to refine their commercial models—keeping in mind the needs of patients and healthcare professionals The coronavirus pandemic has given a new definition to normal by creating an … Read More

The COVID-19 pandemic has resulted in a “mini pandemic” in the form of medical debt and patient stress. We need to be “smart” about managing it ‍ The COVID-19 pandemic has affected the lives and livelihood of American families. At … Read More